financetom
Business
financetom
/
Business
/
Visa, Mastercard $30 billion fee settlement in peril
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Visa, Mastercard $30 billion fee settlement in peril
Jun 13, 2024 4:49 PM

*

Judge signals she is unlikely to approve settlement

*

Critics see little or no benefit for merchants

*

Litigation began in 2005

By Jonathan Stempel

NEW YORK, June 13 (Reuters) - Visa's and

Mastercard's ( MA ) proposed $30 billion antitrust settlement to

limit credit and debit card fees for merchants is in peril,

after a New York judge signaled she was preparing to reject the

accord.

U.S. District Judge Margo Brodie in Brooklyn told lawyers

for the card networks and objectors at a hearing on Thursday

that she will "likely not approve the settlement," according to

court records.

She plans to write an opinion explaining her decision and

reasoning.

Both card networks said they were disappointed. Mastercard ( MA )

called the settlement a "fair resolution" that gave businesses

more flexibility in managing card transactions, and Visa called

it an "appropriate resolution" to the nearly 19-year-old case.

The settlement announced on March 26 was intended to

resolve most claims in the nationwide litigation, with small

businesses comprising more than 90% of the settling merchants.

Businesses have long complained that Visa and Mastercard ( MA )

charge excessive swipe fees, or interchange fees, for processing

credit and debt card payments, and illegally bar them from

steering customers toward cheaper forms of payment.

Swipe fees totaled $172 billion in 2023, and have more than

doubled in the last decade, according to the Merchants Payments

Coalition, which represents retailers, grocers, convenience

stores and gas stations.

Under the settlement, the average 1.5% to 3.5% swipe fee

would fall by at least 0.04 percentage points for three years.

Visa and Mastercard ( MA ) also agreed to cap rates for five years and

remove anti-steering provisions.

Objectors included the National Retail Federation, the

world's largest retailer trade group.

It called the settlement "manifestly insufficient" and its

benefits "meager and temporary," saying it would still let Visa

and Mastercard ( MA ) dictate swipe fees, and impose a "virtually

limitless" ban on future claims by merchants.

The case is In re Payment Card Interchange Fee and Merchant

Discount Antitrust Litigation, U.S. District Court, Eastern

District of New York, No 05-md-01720.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CyberArk Software Lifts Full-Year Outlook as Third-Quarter Results Top Views
CyberArk Software Lifts Full-Year Outlook as Third-Quarter Results Top Views
Nov 13, 2024
08:47 AM EST, 11/13/2024 (MT Newswires) -- CyberArk Software ( CYBR ) raised its full-year outlook on Wednesday as it recorded better-than-expected third-quarter results, while the identity security company named a new finance chief. The Israel-based firm now anticipates adjusted earnings to be in a range of $2.85 to $2.96 per share for 2024, up from its previous projections of...
Zentalis Pharmaceuticals Appoints Julie Eastland as CEO
Zentalis Pharmaceuticals Appoints Julie Eastland as CEO
Nov 13, 2024
08:56 AM EST, 11/13/2024 (MT Newswires) -- Zentalis Pharmaceuticals ( ZNTL ) said Wednesday it appointed Julie Eastland to succeed Kimberly Blackwell as chief executive officer. Blackwell will remain as a strategic advisor to the board of directors, the biopharmaceutical company said. . Eastland previously served as CEO at Harpoon Therapeutics until Merck's ( MRK ) acquisition in early 2024,...
Russia says African, ex-Soviet countries interested in its mpox vaccine
Russia says African, ex-Soviet countries interested in its mpox vaccine
Nov 13, 2024
MOSCOW, Nov 13 (Reuters) - Several African and ex-Soviet countries have expressed interest in buying Russia's vaccine against smallpox and mpox viruses, as well as testing systems and antiviral treatments, Russia's consumer and health watchdog told Reuters. The vaccine, called Orthopoxvac, was developed by the Vektor laboratory in Siberia and registered by Russia's health ministry in 2022 following clinical trials,...
Flow Beverage Inks $13.7 Million Agreement With Beverage Brand
Flow Beverage Inks $13.7 Million Agreement With Beverage Brand
Nov 13, 2024
08:59 AM EST, 11/13/2024 (MT Newswires) -- Flow Beverage ( FLWBF ) on Wednesday said it signed a three-year manufacturing agreement with a beverage brand that guarantees the company at least $13.7 million in revenue. Growth in our co-packing operation has significantly contributed to Flow's recent improvements in profitability and we expect continued momentum on this side of our business...
Copyright 2023-2026 - www.financetom.com All Rights Reserved